Blood sugar changes after a spinal steroid injection in people with and without diabetes
Tracks glucose after dexamethasone spinal injections in adults with and without type 2 diabetes.
Plain-language title generated from the registry record
Registry title: CGM-Based Glycemic Analysis After ESI
Key facts
- Where
- Seoul, South KoreaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 60 years old?
Source: NCT07280780, who can take part
Where in South Korea
- Korea University Anam HospitalSeoul, South KoreaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Korea University Anam Hospital
- Trial code
- NCT07280780
- Record updated
- 12 August 2026
- Original description
The goal of this clinical study is to learn how blood glucose levels change after an epidural steroid injection (ESI) with dexamethasone in adults. It will specifically compare the glycemic response between patients with type 2 diabetes and those without diabetes.Read full original descriptionShow less
Continuous Glucose Monitoring-Based Evaluation of Glycemic Fluctuations Following Epidural Steroid Injections: A Comparative Study by Diabetic Status
The goal of this clinical study is to learn how blood glucose levels change after an epidural steroid injection (ESI) with dexamethasone in adults. It will specifically compare the glycemic response between patients with type 2 diabetes and those without diabetes.
The main questions it aims to answer are:
Does the injection cause higher or longer-lasting blood glucose elevation in diabetic patients compared to non-diabetic patients? How do the mean glucose level and Time in Range (TIR) change after the injection in both groups?
Researchers will compare a Type 2 Diabetes group to a Non-Diabetes group to see the differences in glycemic fluctuations using a continuous glucose monitoring (CGM) device.
Participants will:
* Wear a small CGM sensor on their arm for about 15 days to monitor blood glucose levels continuously * Receive an epidural steroid injection containing 5 mg of dexamethasone on Day 3 * Visit the clinic 3 times (Day 1, Day 3, and Day 15) for sensor attachment, the injection procedure, and data collection
Inclusion: Adults aged 20 to 60 years; Patients scheduled for cervical or lumbar epidural steroid injection at the pain clinic; Patients capable of understanding and using a Continuous Glucose Monitoring (CGM) device.
Exclusion: Patients currently taking or administering steroid medications; Patients who have received an epidural steroid injection within the last 3 months; Patients with Type 1 Diabetes Mellitus; Patients with Cushing's disease; Patients with a known allergy to contrast media; Patients unable to use a Continuous Glucose Monitoring (CGM) device; Patients taking anticoagulants or antiplatelet agents.